WD Tap, G Demetri, P Barnette,
J Desai… - Journal of Clinical …, 2012 - ascopubs.org
Purpose Ganitumab is a fully human monoclonal antibody against type-1 insulin-like growth
factor receptor (IGF1R). An open-label phase II study was conducted to evaluate the efficacy …